One study noted 17 cytokines had a significant upward linear trend with the severity of ME/CFS: CCL11 (Eotaxin-1), CXCL1 (GRO), CXCL10 (IP-10), IFN (interferon)-y, interleukin (IL)-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF- (231)
This depends on how much fluid you receive during treatment, the type of IV fluids you receive, how severe your dehydration is, how active you are after treatment, and whether you continue to drink fluids
Safety Profile & Considerations Current understanding suggests: Generally well-tolerated in research settings No significant toxicity signals in preclinical studies Does not appear to suppress immune function However: Not approved for veterinary use Limited large-scale clinical trials in animals Should only be considered under qualified veterinary supervision What Veterinarians Are Observing In integrative and regenerative veterinary settings, BPC-157 is being explored as part of broader healing protocols
The substance has anti-inflammatory components, hence can lessen sunburn effects
What documentation is required for CPT 96372
